Daniel Salazar
Director/Board Member at Vero Biotech LLC
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Kenneth Joseph Keller | M | 61 |
Daiichi Sankyo, Inc.
 Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | 10 years |
| Todd Brady | M | 45 |
Brace Pharmaceuticals, Inc.
 Brace Pharmaceuticals, Inc. Investment ManagersFinance Brace Pharmaceuticals, Inc (Brace Pharmaceuticals) is a venture capital firm founded in 2013. The firm is headquartered in Atlanta.
Vero Biotech LLC
 Vero Biotech LLC Pharmaceuticals: MajorHealth Technology Vero Biotech LLC is a biotechnology company, which focuses on the design, development and commercialization of inhaled nitric oxide delivery systems to address the unmet medical needs of patients with cardiopulmonary conditions. It develops a drug, GeNOsyl to meet the needs of patients and care providers. The company was founded by David H. Fine in 2006 and is headquartered in Atlanta, GA. | 10 years |
| Brent Furse | M | 55 |
Vero Biotech LLC
Vero Biotech LLC Pharmaceuticals: MajorHealth Technology Vero Biotech LLC is a biotechnology company, which focuses on the design, development and commercialization of inhaled nitric oxide delivery systems to address the unmet medical needs of patients with cardiopulmonary conditions. It develops a drug, GeNOsyl to meet the needs of patients and care providers. The company was founded by David H. Fine in 2006 and is headquartered in Atlanta, GA. | 8 years |
| Vinzenz Ploerer | M | - |
Brace Pharmaceuticals, Inc.
Brace Pharmaceuticals, Inc. Investment ManagersFinance Brace Pharmaceuticals, Inc (Brace Pharmaceuticals) is a venture capital firm founded in 2013. The firm is headquartered in Atlanta. | - |
| Richard van Dyune | M | 70 |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | 21 years |
| Bob Casale | M | 65 |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | - |
| Raymond Schinazi | M | 74 |
Brace Pharmaceuticals, Inc.
Brace Pharmaceuticals, Inc. Investment ManagersFinance Brace Pharmaceuticals, Inc (Brace Pharmaceuticals) is a venture capital firm founded in 2013. The firm is headquartered in Atlanta. | - |
| Luis Manuel Sánchez Carlos | - | - |
Brace Pharmaceuticals, Inc.
Brace Pharmaceuticals, Inc. Investment ManagersFinance Brace Pharmaceuticals, Inc (Brace Pharmaceuticals) is a venture capital firm founded in 2013. The firm is headquartered in Atlanta. | - |
| David Stocker | M | - |
Vero Biotech LLC
Vero Biotech LLC Pharmaceuticals: MajorHealth Technology Vero Biotech LLC is a biotechnology company, which focuses on the design, development and commercialization of inhaled nitric oxide delivery systems to address the unmet medical needs of patients with cardiopulmonary conditions. It develops a drug, GeNOsyl to meet the needs of patients and care providers. The company was founded by David H. Fine in 2006 and is headquartered in Atlanta, GA. | 8 years |
| Ganesh Raghu | M | - |
Vero Biotech LLC
Vero Biotech LLC Pharmaceuticals: MajorHealth Technology Vero Biotech LLC is a biotechnology company, which focuses on the design, development and commercialization of inhaled nitric oxide delivery systems to address the unmet medical needs of patients with cardiopulmonary conditions. It develops a drug, GeNOsyl to meet the needs of patients and care providers. The company was founded by David H. Fine in 2006 and is headquartered in Atlanta, GA. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Glenn Gormley | M | - |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | - |
| Peter Blume-Jensen | M | 62 |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | - |
| John Gargiulo | M | - |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | 2 years |
| Louka T. Katseli | M | 72 |
Princeton University
| 4 years |
| Craig B. Bleifer | M | - |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | 18 years |
| William Frist | M | 72 |
Princeton University
| 4 years |
| Mark Linton | M | - |
Princeton University
| 4 years |
| Peter D. Cleary | M | - |
Princeton University
| 4 years |
| Lorne Hill | M | - |
Princeton University
| 4 years |
| David M. Abromowitz | M | - |
Princeton University
| 4 years |
| Michael A. Tanenbaum | M | - |
Princeton University
| 4 years |
| David Salomon | M | - |
Princeton University
| 4 years |
| Scott Hayworth | M | - |
Princeton University
| 4 years |
| Abigail E. Laufer | F | - |
Princeton University
| 4 years |
| Lorenz Muller | M | 60 |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | 7 years |
| Scott Gottlieb | M | 51 |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | 2 years |
| William P. Urschel | M | - |
Princeton University
| 4 years |
| Mary Cardosa | M | - |
Princeton University
| 4 years |
| Elizabeth Najeeb Halaby | F | - |
Princeton University
| 4 years |
| William Walton | M | 72 |
Princeton University
| 4 years |
| Alan D. Smith | M | - |
Princeton University
| 4 years |
| Rebecca M. Bergman | F | 66 |
Princeton University
| 4 years |
| Jeffrey Gaither Sullivan | M | - |
Princeton University
| 4 years |
| Joseph P. Pieroni | M | - |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | - |
| Christine K. Chiou | F | - |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | - |
| Mahmoud Ghazzi | M | - |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | 5 years |
| Nicholas Allard | M | - |
Princeton University
| 4 years |
| Barry Wihak | M | - |
Princeton University
| 4 years |
| Dori Walton | F | - |
Princeton University
| 4 years |
| Kevin Toner | M | - |
Princeton University
| 4 years |
| Kim Wix | M | - |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | 11 years |
| Nenad Sarapa | M | - |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | 2 years |
| Igor Matushansky | M | 51 |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | 2 years |
| Robert Lisicki | M | 57 |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | 4 years |
| Sandra Clarke | F | 55 |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | 1 years |
| Jim Shepard | M | - |
Princeton University
| 4 years |
| Paul D. Downs | M | - |
Princeton University
| 4 years |
| Virginia Kamsky | F | 70 |
Princeton University
| 4 years |
| Eric Richman | M | 63 |
Brace Pharmaceuticals, Inc.
Brace Pharmaceuticals, Inc. Investment ManagersFinance Brace Pharmaceuticals, Inc (Brace Pharmaceuticals) is a venture capital firm founded in 2013. The firm is headquartered in Atlanta. | 2 years |
| Heidi Miller | M | 70 |
Princeton University
| 4 years |
| Jon Barfield | M | 72 |
Princeton University
| 4 years |
| Richard F. Lambert | M | 67 |
Princeton University
| 4 years |
| Danesha Dixon Smith | F | 51 |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | 5 years |
| Ellen DeSanctis | F | 67 |
Princeton University
| 4 years |
| Bennett Stewart | M | 71 |
Princeton University
| 4 years |
| Jonathan Javitt | M | 67 |
Princeton University
| 4 years |
| Arthur Levinson | M | 73 |
Princeton University
| 3 years |
| John Barry | M | 72 |
Princeton University
| 4 years |
| Howard Feist | M | 68 |
Princeton University
| 4 years |
| Pamela Daley | F | 71 |
Princeton University
| 4 years |
| James L. Shea | M | 70 |
Princeton University
| 4 years |
| Thomas Martin Connelly | M | 72 |
Princeton University
| 4 years |
| Tom Leighton | M | 67 |
Princeton University
| 4 years |
| Kneeland Youngblood | M | 69 |
Princeton University
| 4 years |
| Christopher Day Johnson | M | - |
Princeton University
| 4 years |
| James W. Lytle | M | - |
Princeton University
| 4 years |
| Martin Aaron Sankey | M | - |
Princeton University
| 3 years |
| John Aristotle Phillips | M | - |
Princeton University
| 4 years |
| Alan Talkington | M | - |
Princeton University
| 4 years |
| Robert A. Rosenbaum | M | - |
Princeton University
| 4 years |
| Stephen C. Ferruolo | M | - |
Princeton University
| 1 years |
| William T. Quicksilver | M | - |
Princeton University
| 4 years |
| Michael Gregory Odlum | M | - |
Princeton University
| 4 years |
| Franklin Techar | M | - |
Princeton University
| 4 years |
| Peter Kellogg | M | 67 |
Princeton University
| 4 years |
| John R. Cullinane | M | - |
Princeton University
| 4 years |
| Hiroshi Ozaki | M | 74 |
Princeton University
| 3 years |
| Kathryn Hall | F | 66 |
Princeton University
| 6 years |
| Ronald N. Kahn | M | - |
Princeton University
| 4 years |
| Eric Keith Scholl | M | 69 |
Princeton University
| 4 years |
| Jack Herbert | M | - |
Princeton University
| 4 years |
| Ellie Moffat | F | 68 |
Princeton University
| 4 years |
| Javad Shahidi | M | - |
Daiichi Sankyo, Inc.
Daiichi Sankyo, Inc. Pharmaceuticals: MajorHealth Technology Daiichi Sankyo, Inc. manufactures and supplies pharmaceutical products. It markets therapies in hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, opioid-induced constipation, IV iron therapy and metastatic melanoma. The company was founded in 2006 and is headquartered in Basking Ridge, NJ. | 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 83 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Daniel Salazar
- Personal Network
